The feasibility study of accelated infliximab infusion during maintenance phase
Phase 2
- Conditions
- patient in whom infliximab is indicated(rheumatoid arthritis, Crohn's disease, Ulcerative colitis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis)
- Registration Number
- JPRN-UMIN000007806
- Lead Sponsor
- Chiba University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 54
Inclusion Criteria
Not provided
Exclusion Criteria
1)active serious infection 2)active tuberuculosis infection 3)past history of bronchial asthma 4)past history of hypersensitivity reaction and/or allergy for any drugs and food 5)allergy and/or hypersensitivity for mouse-derived protein 6)demyelinating disease(MS) 7)congestive heart failure 8)pregnant, nursing or likelihood of pregnancy woman 9)unable to birth control during and after 6 months from the latest infliximab administration 10)past treatment history with infliximab and readministration at an interval of over three months 11)Not suitable for participating in the study for any other reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method